ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $68,102,000 | +310.7% | 732,746 | +163.1% | 0.03% | +240.0% |
| Q3 2021 | $16,582,000 | +53.1% | 278,458 | +75.3% | 0.01% | +42.9% |
| Q2 2021 | $10,833,000 | +28.8% | 158,847 | +31.0% | 0.01% | +16.7% |
| Q1 2021 | $8,411,000 | -13.7% | 121,214 | -4.5% | 0.01% | -14.3% |
| Q4 2020 | $9,747,000 | -20.9% | 126,864 | -23.0% | 0.01% | -53.3% |
| Q3 2020 | $12,327,000 | -25.8% | 164,818 | -37.6% | 0.02% | -34.8% |
| Q2 2020 | $16,614,000 | +228.3% | 263,920 | +119.1% | 0.02% | +109.1% |
| Q1 2020 | $5,060,000 | -49.4% | 120,483 | -45.3% | 0.01% | -15.4% |
| Q4 2019 | $9,997,000 | +62.8% | 220,106 | +64.1% | 0.01% | +30.0% |
| Q3 2019 | $6,140,000 | -17.9% | 134,160 | +5.1% | 0.01% | -9.1% |
| Q2 2019 | $7,481,000 | +537.2% | 127,595 | +323.2% | 0.01% | +450.0% |
| Q4 2018 | $1,174,000 | -85.5% | 30,148 | -82.9% | 0.00% | -80.0% |
| Q3 2018 | $8,099,000 | +193.9% | 175,991 | +178.4% | 0.01% | +150.0% |
| Q2 2018 | $2,756,000 | -88.5% | 63,213 | -89.6% | 0.00% | -87.5% |
| Q1 2018 | $23,942,000 | -11.8% | 606,130 | -24.1% | 0.03% | -13.5% |
| Q4 2017 | $27,135,000 | +11.4% | 798,789 | -16.4% | 0.04% | 0.0% |
| Q3 2017 | $24,359,000 | +95.9% | 955,250 | +29.6% | 0.04% | +60.9% |
| Q2 2017 | $12,437,000 | – | 737,225 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |